Our co-founder Max is a former ED patient who tried most of the conventional treatment options (including pharmaceutical solutions, injections, and surgery) before he was able to overcome his issues with a combination of strategies, which are now included in the Regimen program.
Regimen is the first effective certified digital therapy program that empowers you to overcome erection problems, holistically and sustainably.
Regimen is a digital therapy for erection problems (or clinically: erectile dysfunction), developed by some of the leading doctors and researchers worldwide for men like you.
Today we know: More than 7 out of 10 Regimen customers see, on average, greater than 50% improvement in erectile function over the course of the first 12 weeks, and continue to improve in the long run.
And our co-founder Max started the company because he has been able to overcome his own issues with such a program.
It was co-founded by Max, a former patient who was able to overcome his erection problems with a similar program.
They bring their expertise together in the Regimen program to offer you the best strategies to boost your erection.
We’ve worked with leading researchers worldwide to combine all research and knowledge in order to make Regimen as effective as possible.
Regimen has the mission to empower everyone to take care of their erection, efficiently and affordably.
We are proud to work with an international advisory board of researchers and practitioners, including urologists, cardiologists, psychologists and physiotherapists, to ensure that this product remains state-of-the-art.
He was the doctor who helped Max overcome his issues, and in the past few years he has become further specialized in improving erections holistically.
Until health insurances around the world support Regimen, we are committed to make Regimen accessible to all men in need.
Progress is measured based on the global standard of erectile function assessment, known as the International Index of Erectile Function (IIEF-5).
Twenty years ago, he was also an academic advisor to a large pharmaceutical company when they introduced an ED pill that quickly became the market leader.